Sarepta Therapeutics (NQ: SRPT )

70.54 USD -0.92 (-1.29%)

Official Closing Price Updated: 7:59 PM EDT, Apr 9, 2021 Add to My Watchlist

Price and Volume

Volume	781,700
Open	71.62
Bid (Size)	70.75 (1)
Ask (Size)	71.79 (1)
Prev. Close	71.46
Today's Range	70.00 - 71.62
52wk Range	69.56 - 181.83
Shares Outstanding	65,531,046
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Sarepta Therapeutics Announces Fourth Year of Route 79, The Duchenne Scholarship Program

March 23, 2021

Sarepta Therapeutics’ Investigational Gene Therapy SRP-9003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2E Shows Sustained Expression and Functional Improvements 2 Years After Administrat

March 18, 2021

Performance

YTD	-57.32%	-57.32%
1 Month	-18.42%	-18.42%
3 Month	-21.41%	-21.41%
6 Month	-50.63%	-50.63%
1 Year	-36.80%	-36.80%

More News

Sarepta Therapeutics to Present Results from its Gene Therapy and RNA Platforms at the 2021 Annual MDA Clinical and Scientific Conference

March 15, 2021

Implied FAD Analyst Target Price: $122

April 08, 2021

Positive Spin Isn’t Working for Sarepta Therapeutics

April 07, 2021

Is Sarepta Therapeutics Worthy of Redemption?

April 01, 2021

AavantiBio Bolsters Leadership Team with Appointment of Ty Howton as Chief Operating Officer and General Counsel

March 11, 2021

Noteworthy Friday Option Activity: IIVI, WELL, SRPT

March 19, 2021

Sarepta Therapeutics' Long-Term Potential Is in Flux

March 25, 2021

Solid Bio's DMD Gene Therapy Shows Promising Early Data, No New Safety Concerns, But Fails To Cheer Investors

March 16, 2021

Can Sarepta's 'Remarkable' Gene Therapy Pull Shares Out Of The Dumps?

March 19, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.